Saks Jazz's up Tonix board
This article was originally published in Scrip
Executive Summary
Former CEO of Jazz Pharmaceuticals Dr Samuel Saks has joined the board of specialty CNS company Tonix Pharmacueticals. Dr Saks co-founded Jazz in 2003, and remained there as CEO and a director until his resignation in 2009.